Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1

Source: Gallitto, M., Cheng He, R., Inocencio, J.F. et al. Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1. J Neurooncol (2020). DOI: 10.1007/s11060-020-03461-4

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date
Register

Existing members Sign in

No comments yet.